Spermidine synthase is required for virulence of Leishmania donovani

Infection and Immunity

Volumn 79, Issue 7, 2011, Pages 2764-2769

  Gilroy, Caslin ^a   Olenyik, Tamara ^a   Roberts, Sigrid C ^b   Ullman, Buddy ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b School of Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYAMINE; PUTRESCINE; SPERMIDINE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUXOTROPHY; BIOTRANSFORMATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; LEISHMANIA DONOVANI; LEISHMANIASIS; MICROBIAL GROWTH; MOUSE; NONHUMAN; OPEN READING FRAME; PARASITE VIRULENCE; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; PROTOZOAL GENETICS; WILD TYPE;

ANIMALS; CELL LINE; GENE KNOCKOUT TECHNIQUES; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MICE; MUTATION; POLYAMINES; SPERMIDINE SYNTHASE;

EID: 79959450164     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00073-11     Document Type: Article

References (62)

1. Assaraf, Y. G., J. Golenser, D. T. Spira, G. Messer, and U. Bachrach. 1987. Cytostatic effect of DL-alpha-difluoromethylornithine against Plasmodium falciparum and its reversal by diamines and spermidine. Parasitol. Res. 73: 313-318.
2. Bacchi, C. J., et al. 1992. Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor. Antimicrob. Agents Chemother. 36:2736-2740.
3. Bacchi, C. J., et al. 2009. Trypanocidal activity of 8-methyl-5′-{[(Z)-4-aminobut-2-enyl]-(methylamino)}adenosine (Genz-644131), an adenosylmethionine decarboxylase inhibitor. Antimicrob. Agents Chemother. 53: 3269-3272.
4. Bacchi, C. J., and P. P. McCann. 1987. Parasitic protozoa and polyamines, p. 317-344. In P. P. McCann, A. E. Pegg and A. Sjoerdsma (ed.), Inhibition of polyamine metabolism: biological significance and basis for new therapies. Academic Press, Orlando, FL.
5. Bachrach, U. 2005. Naturally occurring polyamines: interaction with macromolecules. Curr. Protein Pept. Sci. 6:559-566.
6. Barker, R. H., Jr., et al. 2009. Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis. Antimicrob. Agents Chemother. 53:2052-2058.
7. Basselin, M., G. H. Coombs, and M. P. Barrett. 2000. Putrescine and spermidine transport in Leishmania. Mol. Biochem. Parasitol. 109:37-46.
8. Bitonti, A. J., et al. 1990. Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase. Antimicrob. Agents Chemother. 34: 1485-1490.
9. Bitonti, A. J., J. A. Dumont, and P. P. McCann. 1986. Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone). Biochem. J. 237:685-689.
10. Blackwell, J. M. 1996. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology. 112(Suppl.):S67-S74.
11. Boitz, J. M., and B. Ullman. 2006. A conditional mutant deficient in hypoxanthine-guanine phosphoribosyltransferase and xanthine phosphoribosyltransferase validates the purine salvage pathway of Leishmania donovani. J. Biol. Chem. 281:16084-16089.
12. Boitz, J. M., et al. 2009. Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host. Infect. Immun. 77:756-63.
13. Buffet, P. A., A. Sulahian, Y. J. Garin, N. Nassar, and F. Derouin. 1995. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob. Agents Chemother. 39:2167-2168.
14. Burri, C., and R. Brun. 2003. Eflornithine for the treatment of human African trypanosomiasis. Parasitol. Res. 90(Suppl. 1):S49-S52.
15. Casero, R. A., and A. E. Pegg. 2009. Polyamine catabolism and disease. Biochem. J. 421:323-338.
16. Chang, K. P., R. F. Steiger, C. Dave, and Y. C. Cheng. 1978. Effects of methylglyoxal bis(ganylhydrazone) on trypanosomatid flagellates: inhibition of growth and nucleoside incorporation in Trypanosoma brucei. J. Protozool. 25:145-149.
17. Clayton, C., et al. 1998. Genetic nomenclature for Trypanosoma and Leishmania. Mol. Biochem. Parasitol. 97:221-224.
18. Danzin, C., P. Marchal, and P. Casara. 1990. Irreversible inhibition of rat S-adenosylmethionine decarboxylase by 5′-([(Z)-4-amino-2-butenyl]methylamino)-5′-deoxyadenosine. Biochem. Pharmacol. 40:1499-1503.
19. Debrabant, A., M. B. Joshi, P. F. Pimenta, and D. M. Dwyer. 2004. Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics. Int. J. Parasitol. 34:205-217.
20. Docampo, R., and S. N. Moreno. 2003. Current chemotherapy of human African trypanosomiasis. Parasitol. Res. 90(Suppl. 1):S10-S13.
21. Fairlamb, A. H., and A. Cerami. 1992. Metabolism and functions of trypanothione in the Kinetoplastida. Annu. Rev. Microbiol. 46:695-729.
22. Garg, R., and A. Dube. 2006. Animal models for vaccine studies for visceral leishmaniasis. Indian J. Med. Res. 123:439-454.
23. Gaur, U., et al. 2007. An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis. J. Immunol. 179:8446-8453.
24. Geary, T. G., S. A. Edgar, and J. D. Jensen. 1986. Drug resistance in protozoa, p. 209-236. In W. C. Campbell and R. S. Rew (ed.), Chemotherapy of parasitic diseases. Plenum Press, New York, NY.
25. Ghoda, L., M. A. Phillips, K. E. Bass, C. C. Wang, and P. Coffino. 1990. Trypanosome ornithine decarboxylase is stable because it lacks sequences found in the carboxyl terminus of the mouse enzyme which target the latter for intracellular degradation. J. Biol. Chem. 265:11823-11826.
26. Ghoda, L., T. van Daalen Wetters, M. Macrae, D. Ascherman, and P. Coffino. 1989. Prevention of rapid intracellular degradation of ODC by a carboxyl-terminal truncation. Science 243:1493-1495.
27. Gillin, F. D., D. S. Reiner, and P. P. McCann. 1984. Inhibition of growth of Giardia lamblia by difluoromethylornithine, a specific inhibitor of polyamine biosynthesis. J. Protozool. 31:161-163.
28. Goyard, S., and S. M. Beverley. 2000. Blasticidin resistance: a new independent marker for stable transfection of Leishmania. Mol. Biochem. Parasitol. 08:249-252.
29. Goyard, S., et al. 2003. An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans. Mol. Biochem. Parasitol. 130:31-2.
30. Gradoni, L., M. A. Iorio, M. Gramiccia, and S. Orsini. 1989. In vivo effect of eflornithine (DFMO) and some related compounds on Leishmania infantum preliminary communication. Farmaco 44:1157-1166.
31. Hasne, M. P., and B. Ullman. 2005. Identification and characterization of a polyamine permease from the protozoan parasite Leishmania major. J. Biol. Chem. 280:15188-15194.
32. Janne, J., et al. 2005. Animal disease models generated by genetic engineering of polyamine metabolism. J. Cell. Mol. Med. 9:865-882.
33. Janne, J., L. Alhonen, M. Pietila, and T. A. Keinanen. 2004. Genetic approaches to the cellular functions of polyamines in mammals. Eur. J. Biochem. 71:877-894.
34. Jiang, Y., et al. 1999. Ornithine decarboxylase gene deletion mutants of Leishmania donovani. J. Biol. Chem. 274:3781-3788.
35. Kaur, K., K. Emmett, P. P. McCann, A. Sjoerdsma, and B. Ullman. 1986. Effects of DL-alpha-difluoromethylornithine on Leishmania donovani promastigotes. J. Protozool. 33:518-521.
36. Kaye, P. M., P. Gorak, M. Murphy, and S. Ross. 1995. Strategies for immune intervention in visceral leishmaniasis. Ann. Trop. Med. Parasitol. 89(Suppl.): 5-81.
37. Keithly, J. S., and A. H. Fairlamb. 1987. Inhibition of Leishmania species by alpha-difluoromethylornithine, p. 749-756. In D. T. Hart (ed.), Leishmaniasis: the current status and new strategies for control, vol. 163. Plenum Press, New York, NY.
38. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
39. Metcalf, B. W., et al. 1978. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogues. J. Am. Chem. Soc. 100:2551-2553.
40. Mishra, J., A. Saxena, and S. Singh. 2007. Chemotherapy of leishmaniasis: past, present and future. Curr. Med. Chem. 14:1153-1169.
41. Mukhopadhyay, R., P. Kapoor, and R. Madhubala. 1996. Characterization of alpha-difluoromethylornithine resistant Leishmania donovani and its susceptibility to other inhibitors of the polyamine biosynthetic pathway. Pharmacol. Res. 34:43-46.
42. Mukhopadhyay, R., and R. Madhubala. 1993. Effect of a bis(benzyl)polyamine analogue, and DL-alpha-difluoromethylornithine on parasite suppression and cellular polyamine levels in golden hamster during Leishmania donovani infection. Pharmacol. Res. 28:359-365.
43. Muleme, H. M., et al. 2009. Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis. J. Immunol. 183:8068-8076.
44. Mullen, A. B., A. J. Baillie, and K. C. Carter. 1998. Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B. Antimicrob. Agents Chemother. 42:2722-2725.
45. Olenyik, T., C. Gilroy, and B. Ullman. 2011. Oral putrescine restores virulence of ornithine decarboxylase-deficient Leishmania donovani in mice. Mol. Biochem. Parasitol. 176:109-111.
46. Osterman, A., N. V. Grishin, L. N. Kinch, and M. A. Phillips. 1994. Formation of functional cross-species heterodimers of ornithine decarboxylase. Biochemistry 33:13662-13667.
47. Phillips, M. A., P. Coffino, and C. C. Wang. 1987. Cloning and sequencing of the ornithine decarboxylase gene from Trypanosoma brucei. Implications for enzyme turnover and selective difluoromethylornithine inhibition. J. Biol. Chem. 262:8721-8727.
48. Reguera, R. M., R. Balana-Fouce, M. Showalter, S. Hickerson, and S. M. Beverley. 2009. Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice. Mol. Biochem. Parasitol. 165:48-56.
49. Reguera, R. M., R. B. Fouce, J. C. Cubria, M. L. Bujidos, and D. Ordonez. 1995. Fluorinated analogues of L-ornithine are powerful inhibitors of ornithine decarboxylase and cell growth of Leishmania infantum promastigotes. Life Sci. 56:223-230.
50. Roberts, S. C., et al. 2001. Genetic analysis of spermidine synthase from Leishmania donovani. Mol. Biochem. Parasitol. 115:217-226.
51. Roberts, S. C., et al. 2002. S-Adenosylmethionine decarboxylase from Leishmania donovani. Molecular, genetic, and biochemical characterization of null mutants and overproducers. J. Biol. Chem. 277:5902-5909.
52. Roberts, S. C., et al. 2004. Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants. J. Biol. Chem. 279:23668-23678.
53. Roberts, S. C., et al. 2007. Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs. Antimicrob. Agents Chemother. 51:438-445.
54. Robinson, K. A., and S. M. Beverley. 2003. Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania. Mol. Biochem. Parasitol. 128:217-228.
55. Sanchez, C. P., et al. 1997. Alpha-difluoromethylornithine-resistant cell lines obtained after one-step selection of Leishmania mexicana promastigote cultures. Biochem. J. 324(Pt 3):847-853.
56. Schechter, P. J., J. L. R. Barlow, and A. Sjoerdsma. 1987. Clinical aspects of inhibition of ornithine decarboxylase with emphasis on therapeutic trials of eflornithine (DFMO) in cancer and protozoan diseases, p. 345-364. In P. P. McCann, A. E. Pegg, and A. Sjoerdsma (ed.), Inhibition of polyamine metabolism: biological significance and basis for new therapies. Academic Press, Orlando, FL.
57. Tabor, C. W., and H. Tabor. 1984. Polyamines. Annu. Rev. Biochem. 53: 749-790.
58. Ulrich, P., R. W. Grady, and A. Cerami. 1982. The trypanocidal activity of various aromatic bisguanylhydrazones in vivo. Drug Dev. Res. 2:219-228.
59. Van Nieuwenhove, S., et al. 1985. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial. Trans. R. Soc. Trop. Med. Hyg. 79:692-698.
60. Wilson, M. E., S. M. Jeronimo, and R. D. Pearson. 2005. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb. Pathog. 8:147-160.
61. Wu, H., et al. 2007. Structure and mechanism of spermidine synthases. Biochemistry 46:8331-8339.
62. Xiao, Y., D. E. McCloskey, and M. A. Phillips. 2009. RNA interferencemediated silencing in ornithine decarboxylase and spermidine synthase genes in Trypanosoma brucei provides insight into regulation of polyamine biosynthesis. Eukaryot. Cell 8:747-755.